Reversible Protein Acetylation and Chromatin Function

可逆蛋白质乙酰化和染色质功能

基本信息

  • 批准号:
    8005210
  • 负责人:
  • 金额:
    $ 12.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-01-14 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Sir2 (or sirtuin) protein family plays critical roles in aging, DMA repair, apoptosis, resistance to cell stress, and metabolism. However, the molecular basis for the varied phenotypes has remained elusive. The majority of sirtuins catalyze a reaction in which the cleavage of NAD+ and histone/protein deacetylation are coupled to the formation of O-acetyl-ADP-ribose (OAADPr), a novel metabolite. Several reports suggest that some sirtuins are mono-ADP-ribosyltransferases, while others have suggested that these enzymes harbor both activities. Detailed mechanistic studies have yet to validate these reports. The dependence on NAD+ and the generation of a potential second messenger offer clues toward understanding their cellular functions. Here, we will focus on answering questions of molecular mechanism, filling major gaps in our understanding of these unique proteins. To address their molecular and biological functions, this proposal outlines a multi-disciplinary approach, involving chemistry, enzymology and genetics. In Aim 1, the catalytic pathways that yield protein deacetylation versus ADP-ribosylation will be elucidated. Aim 2 focuses on understanding how sirtuins recognize specific protein targets. To explore the biological functions of OAADPr, Aim 3 will involve the synthesis of nonhydrolyzable OAADPr analogs, followed by an examination of their ability to act as ligands, substrates and inhibitors against reported protein targets. The experiments in Aim 4 directly probe the cellular function of OAADPr. An assay for the quantitation of cellular OAADPr levels will be coupled with cell- based assays of genetically modified cells. The ability of OAADPr to promote gene silencing in yeast will be assessed. In mammalian cells, the ability of sirtuins and OAADPr to modulate the gating of the TRPM2 ion channel will be determined. Resveratrol, plant polyphenol known to harbor a variety of cardiovascular and neurological health benefits, was reported to be an activator of Sir2 enzymes. Here several hypotheses for the ability of resveratrol to "activate" SIRT1 will be examined in vivo and in vitro (Aim 2). Given the implications for cancer, aging and neurodegeneration, sirtuins have emerged as viable drug targets to treat these diseases. The knowledge gained from this study will provide the major steps towards the design and development of such small molecules.
描述(由申请人提供):Sir2(或 Sirtuin)蛋白家族在衰老、DMA 修复、细胞凋亡、细胞应激抵抗和新陈代谢中发挥着关键作用。然而,不同表型的分子基础仍然难以捉摸。大多数 Sirtuins 催化 NAD+ 裂解和组蛋白/蛋白质脱乙酰化与 O-乙酰基-ADP-核糖 (OAADPr)(一种新型代谢物)的形成相结合的反应。一些报告表明,一些去乙酰化酶是单 ADP-核糖基转移酶,而其他报告则表明这些酶具有这两种活性。详细的机制研究尚未验证这些报告。对 NAD+ 的依赖和潜在第二信使的产生为理解其细胞功能提供了线索。在这里,我们将重点回答分子机制的问题,填补我们对这些独特蛋白质理解的主要空白。为了解决它们的分子和生物功能,该提案概述了一种多学科方法,涉及化学、酶学和遗传学。在目标 1 中,将阐明产生蛋白质脱乙酰化与 ADP-核糖基化的催化途径。目标 2 侧重于了解 Sirtuins 如何识别特定的蛋白质靶点。为了探索 OAADPr 的生物学功能,目标 3 将涉及不可水解的 OAADPr 类似物的合成,然后检查它们作为已报道蛋白质靶标的配体、底物和抑制剂的能力。目标 4 中的实验直接探测 OAADPr 的细胞功能。细胞 OAADPr 水平定量测定将与基于细胞的转基因细胞测定相结合。将评估 OAADPr 促进酵母基因沉默的能力。在哺乳动物细胞中,将确定sirtuins 和OAADPr 调节TRPM2 离子通道门控的能力。白藜芦醇是一种植物多酚,已知具有多种心血管和神经系统健康益处,据报道是 Sir2 酶的激活剂。这里将在体内和体外检查白藜芦醇“激活”SIRT1 能力的几种假设(目标 2)。考虑到对癌症、衰老和神经退行性疾病的影响,去乙酰化酶已成为治疗这些疾病的可行药物靶点。从这项研究中获得的知识将为此类小分子的设计和开发提供主要步骤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M DENU其他文献

JOHN M DENU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M DENU', 18)}}的其他基金

Dynamics and molecular mechanisms linking metabolism and the epigenome
连接代谢和表观基因组的动力学和分子机制
  • 批准号:
    10624003
  • 财政年份:
    2023
  • 资助金额:
    $ 12.32万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10211950
  • 财政年份:
    2021
  • 资助金额:
    $ 12.32万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10434846
  • 财政年份:
    2021
  • 资助金额:
    $ 12.32万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10640272
  • 财政年份:
    2021
  • 资助金额:
    $ 12.32万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10211950
  • 财政年份:
    2021
  • 资助金额:
    $ 12.32万
  • 项目类别:
Linking mitochondrial variation and lifespan amongst five species of Rodentia
将五种啮齿目动物的线粒体变异与寿命联系起来
  • 批准号:
    9077372
  • 财政年份:
    2016
  • 资助金额:
    $ 12.32万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8313913
  • 财政年份:
    2011
  • 资助金额:
    $ 12.32万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8025259
  • 财政年份:
    2011
  • 资助金额:
    $ 12.32万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8706746
  • 财政年份:
    2011
  • 资助金额:
    $ 12.32万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8512636
  • 财政年份:
    2011
  • 资助金额:
    $ 12.32万
  • 项目类别:

相似海外基金

Epigenetic and metabolic mechanisms of environmentally-induced transgenerational germline dysfunction
环境诱导的跨代种系功能障碍的表观遗传和代谢机制
  • 批准号:
    10606928
  • 财政年份:
    2023
  • 资助金额:
    $ 12.32万
  • 项目类别:
Discovery and optimization of antifungal acetyl CoA synthetase inhibitors
抗真菌乙酰辅酶A合成酶抑制剂的发现和优化
  • 批准号:
    10448463
  • 财政年份:
    2021
  • 资助金额:
    $ 12.32万
  • 项目类别:
Discovery and optimization of antifungal acetyl CoA synthetase inhibitors
抗真菌乙酰辅酶A合成酶抑制剂的发现和优化
  • 批准号:
    10646327
  • 财政年份:
    2021
  • 资助金额:
    $ 12.32万
  • 项目类别:
Discovery and optimization of antifungal acetyl CoA synthetase inhibitors
抗真菌乙酰辅酶A合成酶抑制剂的发现和优化
  • 批准号:
    10241688
  • 财政年份:
    2021
  • 资助金额:
    $ 12.32万
  • 项目类别:
Caloric Restriction directs topological chromatin reorganization to enter and maintain enhanced quiescence
热量限制指导拓扑染色质重组进入并维持增强的静止状态
  • 批准号:
    10295030
  • 财政年份:
    2020
  • 资助金额:
    $ 12.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了